Analysts Set Expectations for IntriCon Co.’s Q1 2019 Earnings (IIN)

IntriCon Co. (NASDAQ:IIN) – Analysts at B. Riley issued their Q1 2019 earnings estimates for shares of IntriCon in a research note issued to investors on Tuesday, November 6th. B. Riley analyst A. D’silva forecasts that the technology company will post earnings of $0.24 per share for the quarter. B. Riley currently has a “Buy” rating and a $73.00 price target on the stock. B. Riley also issued estimates for IntriCon’s Q2 2019 earnings at $0.30 EPS and Q4 2019 earnings at $0.28 EPS.

IntriCon (NASDAQ:IIN) last released its quarterly earnings results on Monday, November 5th. The technology company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.02. The firm had revenue of $30.13 million for the quarter, compared to analysts’ expectations of $30.23 million. IntriCon had a net margin of 4.82% and a return on equity of 22.73%.

Several other research analysts have also recently weighed in on the stock. Zacks Investment Research cut shares of IntriCon from a “buy” rating to a “hold” rating in a report on Friday, November 2nd. TheStreet cut shares of IntriCon from a “b” rating to a “c+” rating in a report on Monday, October 1st. Stifel Nicolaus upped their price target on shares of IntriCon from $65.00 to $70.00 and gave the stock a “buy” rating in a report on Friday, September 21st. Finally, Dougherty & Co cut shares of IntriCon from a “buy” rating to a “neutral” rating and set a $12.00 price target on the stock. in a report on Tuesday, September 11th. Two equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the stock. IntriCon currently has an average rating of “Buy” and a consensus price target of $51.25.

IntriCon stock opened at $39.95 on Thursday. The firm has a market capitalization of $371.47 million, a PE ratio of 137.76, a PEG ratio of 4.82 and a beta of 0.93. IntriCon has a fifty-two week low of $14.36 and a fifty-two week high of $76.80. The company has a current ratio of 1.56, a quick ratio of 0.85 and a debt-to-equity ratio of 0.45.

A number of large investors have recently made changes to their positions in IIN. JPMorgan Chase & Co. purchased a new position in IntriCon in the first quarter worth $294,000. Allianz Asset Management GmbH purchased a new position in IntriCon in the first quarter worth $1,050,000. Acadian Asset Management LLC grew its position in IntriCon by 51.8% in the second quarter. Acadian Asset Management LLC now owns 54,464 shares of the technology company’s stock worth $2,195,000 after acquiring an additional 18,590 shares in the last quarter. Integrated Investment Consultants LLC purchased a new position in IntriCon in the second quarter worth $308,000. Finally, Navellier & Associates Inc grew its position in IntriCon by 30.9% in the second quarter. Navellier & Associates Inc now owns 15,142 shares of the technology company’s stock worth $610,000 after acquiring an additional 3,577 shares in the last quarter. Institutional investors own 39.42% of the company’s stock.

In other news, Director Philip Irving Smith sold 10,000 shares of the company’s stock in a transaction on Friday, August 31st. The shares were sold at an average price of $74.18, for a total value of $741,800.00. Following the transaction, the director now owns 6,667 shares of the company’s stock, valued at $494,558.06. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 21.20% of the company’s stock.

About IntriCon

IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical bio-telemetry devices, hearing healthcare, and professional audio communication devices markets.

Read More: Rule of 72

Earnings History and Estimates for IntriCon (NASDAQ:IIN)

Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply